Please login to the form below

Not currently logged in
Email:
Password:

inflammatory diseases

This page shows the latest inflammatory diseases news and features for those working in and with pharma, biotech and healthcare.

Google boosts healthcare business with new hire

Google boosts healthcare business with new hire

Earlier this year, Google’s life science and healthcare division Verily teamed up with Gilead to develop a high-res molecular map of inflammatory diseases. ... This allows identification and characterisation of inflammatory disease mechanisms. Verily

Latest news

  • First Humira biosimilars reach EU market First Humira biosimilars reach EU market

    Humira made $18bn in revenues last year – mostly in the US but with around $6bn from the rest of the world – and is widely used to treat a range of inflammatory ... diseases including rheumatoid arthritis, psoriasis and Crohn's disease.

  • BMS psoriasis drug hits the mark in phase II BMS psoriasis drug hits the mark in phase II

    presence than BMS in the inflammatory disease market.

  • Human Cell Atlas gets new UK funding Human Cell Atlas gets new UK funding

    Researchers say insights gained from the atlas could help to increase understanding of diseases such as asthma and cancer develop and progress, or point to new diagnostic tools and treatments. ... Creating a highly detailed atlas of the skin. A spotlight

  • Mallinckrodt doses first patient in muscular dystrophy trial Mallinckrodt doses first patient in muscular dystrophy trial

    Mallinckrodt has kicked off a phase II trial of its Duchenne muscular dystrophy candidate, a repurposed drug used for years for inflammatory and autoimmune diseases. ... Current formulations of the drug is used to treat inflammatory bowel disease,

  • Sangamo bulks up in cell therapy with TxCell acquisition Sangamo bulks up in cell therapy with TxCell acquisition

    in solid organ transplant patients and with follow-up projects in other autoimmune diseases and inflammatory such as Crohn’s disease and multiple sclerosis. ... generation autologous and allogeneic CAR-Treg cell therapies for use in treating autoimmune

More from news
Approximately 5 fully matching, plus 119 partially matching documents found.

Latest Intelligence

  • ‘How is your day?’ ‘How is your day?’

    Physicians need to be more aware of rare diseases that may hide behind recurring issues that some patients have. ... These are: Primary Immunodeficiency Diseases (PID – causes severe infections); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP

  • The tipping point The tipping point

    In chronic diseases such as rheumatoid arthritis and inflammatory bowel disease, there are significantly greater savings from switching patients compared with initiating biosimilars in naïve patients alone.

  • Taking a lean and careful approach Taking a lean and careful approach

    Its fully human engineered CD3 antibody Foralumab has reached phase II with potential for a wide range of autoimmune and inflammatory diseases such as non-alcoholic steatohepatitis (NASH), primary biliary cholangitis, ... Database of diseases. The

  • Grünenthal's relentless pursuit of relief Grünenthal's relentless pursuit of relief

    It is a good fit strategically for us because it enriches our portfolio in the area of inflammatory and pain-related diseases with high unmet need. ... Pain has nervous and inflammatory components and we are interested in everything around the

  • Deal Watch December 2016 Deal Watch December 2016

    510. Nuevolution (Denmark). Almirall (Spain). Research collaboration. RORγt inhibitors for inflammatory skin diseases and psoriatic arthritis. ... The Scandinavian company, Nuevolution, uses its drug discovery platform Chemetics to discover novel small

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.

Latest from PMHub

  • Impact of Existing and Emerging Inflammatory Diseases Market Trends 2017-2027

    Impact of Existing and Emerging Inflammatory Diseases Market Trends 2017-2027. Future Market Insights has announced the addition of the “ Inflammatory Diseases Market: Global Industry Analysis and Opportunity Assessment 2017-2027"

  • Infographic: Spondyloarthritis

    Infographic: Spondyloarthritis. Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic

  • Infographic: Spondyloarthritis

    Infographic: Spondyloarthritis. Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics